Sherry Neyman, MD
Obstetrics & Gynecology · Austin, TXNPI 1770585069
Payments from drug & device makers
Across 79 payments — averaging $129.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- AbbVie$524
- Hologic Sales And Service, LLC$166
- Millicent US Inc$94
- Davol Inc.$84
- Pfizer$84
- plus $300 from 14 others
What the payments were for
- Travel & lodging$4154%
- Food & beverage$1,80618%
- Education$8,02678%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $9,009 |
| AbbVie | 34 | $524 |
| Hologic Sales And Service, LLC | 8 | $166 |
| Millicent US Inc | 6 | $94 |
| Davol Inc. | 1 | $84 |
| Pfizer | 4 | $84 |
| Astellas Pharma US Inc | 2 | $55 |
| Merck | 3 | $44 |
| Ascend Therapeutics US, LLC | 2 | $28 |
| Baxter Healthcare | 1 | $25 |
| Duchesnay USA Incorporated | 1 | $20 |
| Coloplast | 1 | $19 |
| Covidien LP | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Axonics, Inc. | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Boston Scientific | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Channel Medsystems, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,975
How this compares
$10,261 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 60 | $5,349 |
| Estradiol (Twice Weekly)Estradiol | 30 | $2,391 |
| ProgesteroneProgesterone, Micronized | 72 | $2,363 |
| ValacyclovirValacyclovir Hcl | 25 | $943 |
| Spironolactone | 13 | $97 |
| Misoprostol | 12 | $18 |
| Fluconazole | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Austin
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Melissa WinnAustin$1.1M
- Laura DowningAustin$464K
- Ana EduardoAustin$303K
- Stephanie ReichAustin$249K
- Renu ChalasaniAustin$156K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.